Stocks rose Friday on the heels of a volatile session a day earlier, when stocks were whipsawed amid conflicting signals over the results of a clinical trial for a coronavirus antiviral treatment candidate. The latest batch of economic data released Friday morning showed further signs of stress on the U.S. manufacturing sector, with durable goods orders down the most in six years in March.
